AU626255B2 - Factor viii binding domain of von willebrand factor - Google Patents
Factor viii binding domain of von willebrand factor Download PDFInfo
- Publication number
- AU626255B2 AU626255B2 AU15271/88A AU1527188A AU626255B2 AU 626255 B2 AU626255 B2 AU 626255B2 AU 15271/88 A AU15271/88 A AU 15271/88A AU 1527188 A AU1527188 A AU 1527188A AU 626255 B2 AU626255 B2 AU 626255B2
- Authority
- AU
- Australia
- Prior art keywords
- factor viii
- polypeptide
- amino acid
- factor
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07045032 US5043429B1 (en) | 1987-05-01 | 1987-05-01 | Protein fragments containing factor VIII binding domain of von willebrand factor |
US045032 | 1987-05-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU1527188A AU1527188A (en) | 1988-11-03 |
AU626255B2 true AU626255B2 (en) | 1992-07-30 |
Family
ID=21935641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU15271/88A Expired AU626255B2 (en) | 1987-05-01 | 1988-04-28 | Factor viii binding domain of von willebrand factor |
Country Status (9)
Country | Link |
---|---|
US (3) | US5043429B1 (fr) |
EP (1) | EP0294025B1 (fr) |
JP (1) | JP2631127B2 (fr) |
AT (1) | ATE133183T1 (fr) |
AU (1) | AU626255B2 (fr) |
CA (1) | CA1341097C (fr) |
DE (1) | DE3854904T2 (fr) |
ES (1) | ES2081804T3 (fr) |
GR (1) | GR3018870T3 (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5043429B1 (en) * | 1987-05-01 | 1997-10-14 | Scripps Research Inst | Protein fragments containing factor VIII binding domain of von willebrand factor |
FR2632309B1 (fr) * | 1988-06-07 | 1990-08-24 | Lille Transfusion Sanguine | Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus |
US6008193A (en) * | 1990-03-02 | 1999-12-28 | Bio-Technology General Corp. | Methods of using human von Willebrand factor GPIb binding domain polypeptides |
US5849536A (en) * | 1990-03-02 | 1998-12-15 | Bio-Technology General Corp. | Cloning and production of human von willebrand factor GPIb binding domain polypeptides and methods of using same |
US5530100A (en) * | 1990-05-07 | 1996-06-25 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Methods for purification of recombinantly produced proteins |
US5610148A (en) * | 1991-01-18 | 1997-03-11 | University College London | Macroscopically oriented cell adhesion protein for wound treatment |
US5629287A (en) * | 1991-01-18 | 1997-05-13 | University College London | Depot formulations |
US5847086A (en) * | 1991-06-20 | 1998-12-08 | Centeon L.L.C. | Therapeutic fragments of von Willebrand factor |
EP0590048B1 (fr) * | 1991-06-20 | 2004-12-01 | Aventis Behring L.L.C. | Un procede pour preparer des fragments therapeutiques du facteur de von willebrand |
CA2117780A1 (fr) * | 1992-04-10 | 1993-10-28 | Paul F. Goetinck | Proteine structurale de cartilage et modes d'emploi |
US6005077A (en) * | 1995-11-10 | 1999-12-21 | Immuno Aktiengesellschaft | Use of von willebrand factor and pharmaceutical formulation |
DE19740310A1 (de) * | 1997-09-13 | 1999-04-01 | Octapharma Ag | Peptid mit Affinität zu Gerinnungsfaktor VIII |
KR100398058B1 (ko) * | 2001-05-18 | 2003-09-19 | 주식회사 경동도시가스 | 수식된 θ-알루미나에 담지되어 이루어진 니켈계 개질촉매및 이를 이용한 천연가스로부터 합성가스의 제조방법 |
JP2008512098A (ja) * | 2004-09-07 | 2008-04-24 | アーケミックス コーポレイション | フォン・ビルブラント因子に対するアプタマー、および血栓性疾患の処置剤としてのその使用 |
US7566701B2 (en) * | 2004-09-07 | 2009-07-28 | Archemix Corp. | Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics |
WO2006029258A2 (fr) * | 2004-09-07 | 2006-03-16 | Archemix Corp. | Chimie medicale utilisant des aptameres |
WO2008150495A2 (fr) * | 2007-06-01 | 2008-12-11 | Archemix Corp. | Formulations d'aptamère vwf et procédés d'utilisation |
CA2780542C (fr) | 2009-11-13 | 2020-03-24 | Grifols Therapeutics Inc. | Preparations contenant le facteur de von willebrand (vwf) et procedes, coffrets et utilisations s'y rapportant |
AU2011343813B2 (en) | 2010-12-15 | 2015-05-21 | Takeda Pharmaceutical Company Limited | Eluate collection using conductivity gradient |
WO2013093760A2 (fr) | 2011-12-19 | 2013-06-27 | Grifols, S.A. | Compositions, procédés et trousses pour la préparation de protéines recombinantes sialylées |
NL2013007B1 (en) | 2014-06-16 | 2016-07-05 | Ablynx Nv | Methods of treating TTP with immunoglobulin single variable domains and uses thereof. |
EP3476937A4 (fr) | 2016-06-24 | 2019-12-04 | Mogam Institute for Biomedical Research | Protéine chimère comprenant les facteurs fviii et vwf, et utilisation de celle-ci |
US11999797B2 (en) | 2018-02-06 | 2024-06-04 | Ablynx N.V. | Methods of treating initial episode of TTP with immunoglobulin single variable domains |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4361509A (en) * | 1981-12-14 | 1982-11-30 | Scripps Clinic And Research Foundation | Ultrapurification of factor VIII using monoclonal antibodies |
US4661471A (en) * | 1984-04-10 | 1987-04-28 | New England Deaconess Hospital | Method of inhibiting and inducing human platelet aggregation |
US4683291A (en) * | 1985-10-28 | 1987-07-28 | Scripps Clinic And Research Foundation | Platelet binding inhibitors |
JP2525022B2 (ja) * | 1986-01-03 | 1996-08-14 | ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド | ▲VIII▼:c因子型タンパク質の改良生産方法 |
US5198349A (en) * | 1986-01-03 | 1993-03-30 | Genetics Institute, Inc. | Method for producing factor VIII:C and analogs |
US5043429B1 (en) * | 1987-05-01 | 1997-10-14 | Scripps Research Inst | Protein fragments containing factor VIII binding domain of von willebrand factor |
-
1987
- 1987-05-01 US US07045032 patent/US5043429B1/en not_active Expired - Lifetime
-
1988
- 1988-04-26 CA CA000565057A patent/CA1341097C/fr not_active Expired - Fee Related
- 1988-04-27 EP EP88303796A patent/EP0294025B1/fr not_active Expired - Lifetime
- 1988-04-27 DE DE3854904T patent/DE3854904T2/de not_active Expired - Lifetime
- 1988-04-27 AT AT88303796T patent/ATE133183T1/de not_active IP Right Cessation
- 1988-04-27 ES ES88303796T patent/ES2081804T3/es not_active Expired - Lifetime
- 1988-04-28 AU AU15271/88A patent/AU626255B2/en not_active Expired
- 1988-05-02 JP JP63109854A patent/JP2631127B2/ja not_active Expired - Lifetime
-
1991
- 1991-07-03 US US07725560 patent/US5260274B1/en not_active Expired - Lifetime
-
1995
- 1995-03-24 US US08/410,574 patent/US5597711A/en not_active Expired - Lifetime
-
1996
- 1996-02-01 GR GR960400264T patent/GR3018870T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE3854904T2 (de) | 1996-07-04 |
AU1527188A (en) | 1988-11-03 |
DE3854904D1 (de) | 1996-02-29 |
JPS6456697A (en) | 1989-03-03 |
US5260274A (en) | 1993-11-09 |
US5043429A (en) | 1991-08-27 |
EP0294025A3 (en) | 1989-11-08 |
ES2081804T3 (es) | 1996-03-16 |
JP2631127B2 (ja) | 1997-07-16 |
US5043429B1 (en) | 1997-10-14 |
US5597711A (en) | 1997-01-28 |
US5260274B1 (en) | 1998-01-20 |
GR3018870T3 (en) | 1996-05-31 |
EP0294025B1 (fr) | 1996-01-17 |
CA1341097C (fr) | 2000-09-12 |
ATE133183T1 (de) | 1996-02-15 |
EP0294025A2 (fr) | 1988-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU626255B2 (en) | Factor viii binding domain of von willebrand factor | |
US4877614A (en) | Biologically active fragments of human antihemophilic factor and method for preparation thereof | |
AU780775B2 (en) | Factor IX/factor IXa antibodies and antibody derivatives | |
Fass et al. | Monoclonal antibodies to porcine factor VIII coagulant and their use in the isolation of active coagulant protein | |
AU665752B2 (en) | Recombinant thrombin receptor and related pharmaceuticals | |
US7910094B2 (en) | Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV | |
US8586538B2 (en) | Method of treating a patient suffering from a bleeding disorder comprising administering an antibody against the A3-C1 of FVIII | |
CA1341506C (fr) | Polypeptides coagulants analogues au facteur viii ainsi que des anticorps monoclonaux que leur sont specifiques | |
KR940002033B1 (ko) | 단백질 c에 대해 특이성이 있는 단클론성 항체 및 항체의 분리방법 | |
EP0182372A2 (fr) | Polypeptides facteur VIII coagulant | |
EP0319315A2 (fr) | Domaine du facteur VIII liant le facteur de von Willebrand | |
EP0972781B1 (fr) | Polypeptides de la protéine S et leurs utilisations | |
EP0640100A1 (fr) | Modulation des interactions entre cd36 et la thrombospondine | |
EP0317279A2 (fr) | Peptides pour l'usage dans la purification du facteur-VIII | |
EP1399556B1 (fr) | Epitopes antigenes du factor viii, inhibiteurs diriges contre ces epitopes et leur utilisation | |
JPH10179159A (ja) | モノクローナル抗体、免疫吸着剤としての使用およびヒトプラスミノーゲンの製造方法 | |
JPH06205696A (ja) | 非天然型ヒト凝固第viii因子l鎖結合性モノクローナル抗体 |